Clinical Trials Logo

Metabolic Diseases clinical trials

View clinical trials related to Metabolic Diseases.

Filter by:

NCT ID: NCT04614116 Completed - Metabolism Disorder Clinical Trials

Cold Induced Futile Cycles In White Adipose Tissue

Metabol
Start date: June 15, 2021
Phase: N/A
Study type: Interventional

Investigation of futile cycles in white adipose tissue under cold conditions for thermogenesis using two substitutes for glucose metabolism (18F-FDG and 13C-Glucose).

NCT ID: NCT04613700 Completed - Obesity Clinical Trials

The Role of Secretin on the Energy Homeostasis

THE-ROSE
Start date: March 1, 2020
Phase: N/A
Study type: Interventional

As of last year, new insight into the function of secretin was brought about as rodent studies showed secretin to possess potential body weight-regulating effects. In these studies, secretin was shown to increase non-shivering thermogenesis in brown adipose tissue (BAT), decrease meal size and promote meal discontinuation. The mechanisms behind these regulatory effect of secretin on energy homeostasis are unclear,

NCT ID: NCT04583657 Completed - Healthy Clinical Trials

Intestinal Tolerance & Health Effects of Daily Consumption of Two Eggs With Fatty Acid Profile Related to Metabolic Disorders

Oil4Egg
Start date: May 20, 2019
Phase: N/A
Study type: Interventional

This study has two objectives: 1) to check that the daily consumption of two eggs with a particular fatty acid pattern rich in n-3 polyunsaturated fatty acids (α-linolenic acid, docosahexaenoic acid), conjugated-linoleic acid and conjugated-linolenic acid is well tolerated by the consumer ; 2) to evaluate the effects of the consumption of these eggs on health parameters in subjects presenting a risk of developing a metabolic disorder. This monocentric study is an interventional, randomized, double-blind, control study.

NCT ID: NCT04582643 Completed - Metabolic Disease Clinical Trials

Pilot Test of a Healthy Metabolic Behaviour Tool

Start date: July 1, 2021
Phase: N/A
Study type: Interventional

This study aims to validate and pilot test the short-term intervention effect of a newly developed healthy metabolic behaviour tool, named as the 6P tool, on dietary attitude/ practice and body weight changes over one month among overweight and obese women. A total of 50 women, aged 21-40 years, BMI ≥25 kg/m2, who are attending the preconception clinic and planning for a pregnancy over the next one year, will be invited to participate in this pilot study. The recruitment period is estimated to take up to 10 weeks, with subsequent 1 month follow-up visit.

NCT ID: NCT04574830 Completed - Clinical trials for Glycogen Storage Disease Type III

Study to Evaluate Biomarkers and Clinical Manifestations in Individuals With Glycogen Storage Disease Type III (GSD III)

Start date: November 23, 2020
Phase:
Study type: Observational

The primary objective of this study is to evaluate potential biomarkers of GSD III.

NCT ID: NCT04556500 Completed - Metabolic Disease Clinical Trials

Turkish Version of the Affordance in the Home Environment for Motor Development-Toddler (AHEMD-T)

Start date: October 1, 2020
Phase:
Study type: Observational

This study aimed to translate the Affordance in the Home Environment for Motor Development -Toddler (AHEMD-T) into Turkish and examine its psychometric properties.

NCT ID: NCT04556487 Completed - Metabolic Disease Clinical Trials

Turkish Affordances in the Home Environment for Motor Development-Infant Scale (AHEMD-IS)

Start date: October 1, 2020
Phase:
Study type: Observational

Environment which children live and grown is very important for the all development stages. In Turkey there is no measurement for home environment evaluation so our aim is to investigate the Psychometric Properties of the Turkish version of Affordances in the Home Environment for Motor Development-Infant Scale (AHEMD-IS) in a sample of Turkısh children.

NCT ID: NCT04539340 Completed - Metabolic Diseases Clinical Trials

A Multi-cohort Study of the Tolerance, Safety, and Pharmacokinetics of GNR-055 in Healthy Volunteers

Start date: February 28, 2020
Phase: Phase 1
Study type: Interventional

It is a phase I open-label single-dose, dose-escalation cohort study to evaluate of the tolerance, safety, and pharmacokinetics of GNR-055 in healthy volunteers

NCT ID: NCT04529473 Completed - Metabolic Syndrome Clinical Trials

Efficacy and Safety of 12-weeks Supplementation of Eubacterium Hallii on Insulin Sensitivity and Glycaemic Control

Start date: February 3, 2021
Phase: N/A
Study type: Interventional

This 12 week placebo-controlled study evaluates the efficacy and safety of E. hallii supplementation.

NCT ID: NCT04518605 Completed - Clinical trials for Overweight and Obesity

Breakfast for Young Females

NyStart2
Start date: August 15, 2020
Phase: N/A
Study type: Interventional

Investigators will test the health effects of eating a dairy-based protein-rich breakfast or isocaloric breakfast and performing regular physical exercise training for 12 weeks in young overweight women (2 x 2 factorial design). Measurements of body composition, physical fitness, metabolic health parameters, faeces and urine metabolites, and food diary will be collected.